Twist Bioscience Corp（TWST）今日盘前股价大跌6.22%，引发市场关注。
消息面上，公司公布了最新财季业绩。尽管营收同比增长23.2%至1.184亿美元，并超出分析师预期，同时公司上调了全年营收指引，但盈利端的表现拖累了股价。财报显示，公司当季每股亏损0.56美元，而去年同期为每股盈利0.33美元，业绩由盈转亏，且亏损幅度大于市场预期的每股亏损0.51美元。
市场分析认为，尽管公司收入增长强劲且对未来指引乐观，但盈利能力的显著恶化成为投资者关注的焦点，对盈利端的担忧主导了本次盘前的抛售。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.